CN102199578B - Mutant enzyme of glutamate dehydrogenase and construction method thereof - Google Patents
Mutant enzyme of glutamate dehydrogenase and construction method thereof Download PDFInfo
- Publication number
- CN102199578B CN102199578B CN 201110059834 CN201110059834A CN102199578B CN 102199578 B CN102199578 B CN 102199578B CN 201110059834 CN201110059834 CN 201110059834 CN 201110059834 A CN201110059834 A CN 201110059834A CN 102199578 B CN102199578 B CN 102199578B
- Authority
- CN
- China
- Prior art keywords
- gly
- ala
- val
- leu
- glutamate dehydrogenase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 23
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 title claims abstract description 16
- 102000016901 Glutamate dehydrogenase Human genes 0.000 title claims abstract description 15
- 238000010276 construction Methods 0.000 title abstract description 8
- 150000001413 amino acids Chemical group 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 11
- 235000001014 amino acid Nutrition 0.000 abstract description 14
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 7
- 239000013612 plasmid Substances 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 4
- 229930182817 methionine Natural products 0.000 abstract description 4
- 108020005199 Dehydrogenases Proteins 0.000 abstract description 3
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 abstract description 3
- 235000013922 glutamic acid Nutrition 0.000 abstract description 2
- 239000004220 glutamic acid Substances 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 13
- 238000012408 PCR amplification Methods 0.000 description 10
- 101150019455 gdh gene Proteins 0.000 description 10
- 239000000758 substrate Substances 0.000 description 8
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 7
- 238000006555 catalytic reaction Methods 0.000 description 7
- 238000004925 denaturation Methods 0.000 description 7
- 230000036425 denaturation Effects 0.000 description 7
- 229960002989 glutamic acid Drugs 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 2
- 108010028658 Leucine Dehydrogenase Proteins 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 101710100604 Valine dehydrogenase Proteins 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000009615 deamination Effects 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 1
- PJNSIUPOXFBHDM-GUBZILKMSA-N Ala-Arg-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O PJNSIUPOXFBHDM-GUBZILKMSA-N 0.000 description 1
- KUDREHRZRIVKHS-UWJYBYFXSA-N Ala-Asp-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KUDREHRZRIVKHS-UWJYBYFXSA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- NVCIXQYNWYTLDO-IHRRRGAJSA-N Arg-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N NVCIXQYNWYTLDO-IHRRRGAJSA-N 0.000 description 1
- NIUDXSFNLBIWOB-DCAQKATOSA-N Arg-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NIUDXSFNLBIWOB-DCAQKATOSA-N 0.000 description 1
- WMEVEPXNCMKNGH-IHRRRGAJSA-N Arg-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WMEVEPXNCMKNGH-IHRRRGAJSA-N 0.000 description 1
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 1
- FIQKRDXFTANIEJ-ULQDDVLXSA-N Arg-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FIQKRDXFTANIEJ-ULQDDVLXSA-N 0.000 description 1
- IGFJVXOATGZTHD-UHFFFAOYSA-N Arg-Phe-His Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc2c[nH]cn2)C(=O)O IGFJVXOATGZTHD-UHFFFAOYSA-N 0.000 description 1
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 1
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 1
- VDCIPFYVCICPEC-FXQIFTODSA-N Asn-Arg-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O VDCIPFYVCICPEC-FXQIFTODSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- UYXXMIZGHYKYAT-NHCYSSNCSA-N Asn-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)N)N UYXXMIZGHYKYAT-NHCYSSNCSA-N 0.000 description 1
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 1
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 1
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 1
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- BVFQOPGFOQVZTE-ACZMJKKPSA-N Cys-Gln-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O BVFQOPGFOQVZTE-ACZMJKKPSA-N 0.000 description 1
- VIOQRFNAZDMVLO-NRPADANISA-N Cys-Val-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIOQRFNAZDMVLO-NRPADANISA-N 0.000 description 1
- ZXGDAZLSOSYSBA-IHRRRGAJSA-N Cys-Val-Phe Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZXGDAZLSOSYSBA-IHRRRGAJSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- CKNUKHBRCSMKMO-XHNCKOQMSA-N Gln-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O CKNUKHBRCSMKMO-XHNCKOQMSA-N 0.000 description 1
- AQPZYBSRDRZBAG-AVGNSLFASA-N Gln-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N AQPZYBSRDRZBAG-AVGNSLFASA-N 0.000 description 1
- XIYWAJQIWLXXAF-XKBZYTNZSA-N Gln-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O XIYWAJQIWLXXAF-XKBZYTNZSA-N 0.000 description 1
- HUWSBFYAGXCXKC-CIUDSAMLSA-N Glu-Ala-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O HUWSBFYAGXCXKC-CIUDSAMLSA-N 0.000 description 1
- VFZIDQZAEBORGY-GLLZPBPUSA-N Glu-Gln-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VFZIDQZAEBORGY-GLLZPBPUSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- IOUQWHIEQYQVFD-JYJNAYRXSA-N Glu-Leu-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IOUQWHIEQYQVFD-JYJNAYRXSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- XLFHCWHXKSFVIB-BQBZGAKWSA-N Gly-Gln-Gln Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLFHCWHXKSFVIB-BQBZGAKWSA-N 0.000 description 1
- HQRHFUYMGCHHJS-LURJTMIESA-N Gly-Gly-Arg Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N HQRHFUYMGCHHJS-LURJTMIESA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- JNGHLWWFPGIJER-STQMWFEESA-N Gly-Pro-Tyr Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JNGHLWWFPGIJER-STQMWFEESA-N 0.000 description 1
- FNXSYBOHALPRHV-ONGXEEELSA-N Gly-Val-Lys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN FNXSYBOHALPRHV-ONGXEEELSA-N 0.000 description 1
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 1
- BILZDIPAKWZFSG-PYJNHQTQSA-N His-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N BILZDIPAKWZFSG-PYJNHQTQSA-N 0.000 description 1
- XDIVYNSPYBLSME-DCAQKATOSA-N His-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N XDIVYNSPYBLSME-DCAQKATOSA-N 0.000 description 1
- FBVHRDXSCYELMI-PBCZWWQYSA-N His-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O FBVHRDXSCYELMI-PBCZWWQYSA-N 0.000 description 1
- LQSBBHNVAVNZSX-GHCJXIJMSA-N Ile-Ala-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N LQSBBHNVAVNZSX-GHCJXIJMSA-N 0.000 description 1
- VOBYAKCXGQQFLR-LSJOCFKGSA-N Ile-Gly-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VOBYAKCXGQQFLR-LSJOCFKGSA-N 0.000 description 1
- TVYWVSJGSHQWMT-AJNGGQMLSA-N Ile-Leu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N TVYWVSJGSHQWMT-AJNGGQMLSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- JVTYXRRFZCEPPK-RHYQMDGZSA-N Leu-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)N)O JVTYXRRFZCEPPK-RHYQMDGZSA-N 0.000 description 1
- ONHCDMBHPQIPAI-YTQUADARSA-N Leu-Trp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N ONHCDMBHPQIPAI-YTQUADARSA-N 0.000 description 1
- GQUDMNDPQTXZRV-DCAQKATOSA-N Lys-Arg-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GQUDMNDPQTXZRV-DCAQKATOSA-N 0.000 description 1
- BRSGXFITDXFMFF-IHRRRGAJSA-N Lys-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N BRSGXFITDXFMFF-IHRRRGAJSA-N 0.000 description 1
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 1
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 1
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 1
- KUQWVNFMZLHAPA-CIUDSAMLSA-N Met-Ala-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O KUQWVNFMZLHAPA-CIUDSAMLSA-N 0.000 description 1
- GAELMDJMQDUDLJ-BQBZGAKWSA-N Met-Ala-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O GAELMDJMQDUDLJ-BQBZGAKWSA-N 0.000 description 1
- WYEXWKAWMNJKPN-UBHSHLNASA-N Met-Ala-Phe Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N WYEXWKAWMNJKPN-UBHSHLNASA-N 0.000 description 1
- OBVHKUFUDCPZDW-JYJNAYRXSA-N Met-Arg-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OBVHKUFUDCPZDW-JYJNAYRXSA-N 0.000 description 1
- MDXAULHWGWETHF-SRVKXCTJSA-N Met-Arg-Val Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCNC(N)=N MDXAULHWGWETHF-SRVKXCTJSA-N 0.000 description 1
- UZWMJZSOXGOVIN-LURJTMIESA-N Met-Gly-Gly Chemical compound CSCC[C@H](N)C(=O)NCC(=O)NCC(O)=O UZWMJZSOXGOVIN-LURJTMIESA-N 0.000 description 1
- OXIWIYOJVNOKOV-SRVKXCTJSA-N Met-Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CCCNC(N)=N OXIWIYOJVNOKOV-SRVKXCTJSA-N 0.000 description 1
- LUYURUYVNYGKGM-RCWTZXSCSA-N Met-Pro-Thr Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUYURUYVNYGKGM-RCWTZXSCSA-N 0.000 description 1
- QYIGOFGUOVTAHK-ZJDVBMNYSA-N Met-Thr-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QYIGOFGUOVTAHK-ZJDVBMNYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- FIRWJEJVFFGXSH-RYUDHWBXSA-N Phe-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 FIRWJEJVFFGXSH-RYUDHWBXSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 1
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 1
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 1
- RMKGXGPQIPLTFC-KKUMJFAQSA-N Phe-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RMKGXGPQIPLTFC-KKUMJFAQSA-N 0.000 description 1
- SFECXGVELZFBFJ-VEVYYDQMSA-N Pro-Asp-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFECXGVELZFBFJ-VEVYYDQMSA-N 0.000 description 1
- FKKHDBFNOLCYQM-FXQIFTODSA-N Pro-Cys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O FKKHDBFNOLCYQM-FXQIFTODSA-N 0.000 description 1
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 1
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 1
- SSWJYJHXQOYTSP-SRVKXCTJSA-N Pro-His-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O SSWJYJHXQOYTSP-SRVKXCTJSA-N 0.000 description 1
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 1
- VPBQDHMASPJHGY-JYJNAYRXSA-N Pro-Trp-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CO)C(=O)O VPBQDHMASPJHGY-JYJNAYRXSA-N 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- OLIJLNWFEQEFDM-SRVKXCTJSA-N Ser-Asp-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLIJLNWFEQEFDM-SRVKXCTJSA-N 0.000 description 1
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 1
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 1
- GCXFWAZRHBRYEM-NUMRIWBASA-N Thr-Gln-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O GCXFWAZRHBRYEM-NUMRIWBASA-N 0.000 description 1
- OQCXTUQTKQFDCX-HTUGSXCWSA-N Thr-Glu-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O OQCXTUQTKQFDCX-HTUGSXCWSA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- JQAWYCUUFIMTHE-WLTAIBSBSA-N Thr-Gly-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JQAWYCUUFIMTHE-WLTAIBSBSA-N 0.000 description 1
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 1
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
- ICNFHVUVCNWUAB-SZMVWBNQSA-N Trp-Arg-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ICNFHVUVCNWUAB-SZMVWBNQSA-N 0.000 description 1
- NLLARHRWSFNEMH-NUTKFTJISA-N Trp-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N NLLARHRWSFNEMH-NUTKFTJISA-N 0.000 description 1
- NSOMQRHZMJMZIE-GVARAGBVSA-N Tyr-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NSOMQRHZMJMZIE-GVARAGBVSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 1
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 1
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 1
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 1
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 1
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 1
- KKHRWGYHBZORMQ-NHCYSSNCSA-N Val-Arg-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKHRWGYHBZORMQ-NHCYSSNCSA-N 0.000 description 1
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 1
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 1
- MDYSKHBSPXUOPV-JSGCOSHPSA-N Val-Gly-Phe Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MDYSKHBSPXUOPV-JSGCOSHPSA-N 0.000 description 1
- WHNSHJJNWNSTSU-BZSNNMDCSA-N Val-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 WHNSHJJNWNSTSU-BZSNNMDCSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 108010033011 des-Arg- enterostatin Proteins 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010072591 lysyl-leucyl-alanyl-arginine Proteins 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010078226 phenylalanine oxidase Proteins 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010003885 valyl-prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses mutant enzyme of glutamate dehydrogenase and a construction method thereof. The mutant enzyme has an amino acid sequence shown as SEQ ID NO: 1. The mutant gene is well expressed in a heterologous host, namely Escherichia coli; and expressed proteins are one kind of dehydrogenases which can catalyze various amino acids. The method mainly comprises the following steps of: (1) obtaining a glutamate dehydrogenase gene gdh and constructing a recombinant plasmid; (2) constructing a mutant strain; (3) constructing an expression strain; and (4) expressing and purifying. Compared with the prior art, the generated engineering bacteria not only can catalyze glutamic acid, but also can catalyze methionine and norleucine.
Description
Technical field
The present invention relates to utilize mutant enzyme and construction process thereof, belong to especially mutant enzyme and the construction process thereof of glutamate dehydrogenase.
Background technology
Amino acid dehydrogenase family (amino acid dehydrogenases, EC 1.4.1), this family protein utilizes NAD
+Perhaps NADP
+For cofactor catalytic amino acid oxidase deamination forms corresponding ketone acid.React as follows:
This family comprises glutamate dehydrogenase (Glutamate dehydrogenase, GDH), leucine dehydrogenase (Leucine dehydrogenase), valine dehydrogenase (Valine dehydrogenase) and phenylalanine desaturase (Phenylalanine dehydrogenase).Because these amino acid dehydrogenases can the specific reaction of catalysis, they are often used in diet and medicine is amino acid whose synthetic, can also be used for the clinical detection of amino acid and ammonia.But it is similar different at aspects such as substrate specificity, stability and salt tolerances that some members of this family share sequential structure.
Glutamate dehydrogenase (Glutamate dehydrogenase, GDH) can be with NAD (P)
+Reversible reaction for coenzyme catalysis glucose oxidation deamination and reduction ammonia.Extensively being present in the organisms such as bacterium, animal and plant, is the important enzyme that connects carbon and nitrogen metabolism, significant for vital movements such as the balance of intracellular environment oxidation-reduction quality and biological metabolisms.Glutamate dehydrogenase is the key enzyme in the synthetic glutamic acid metabolism process of glutamate producing bacterium, can also be used for enzyme electrodes makes, preparation of medical reagent urea nitrogen test kit etc. in medical diagnosis such as medicine industry, GDH measures and also can be used as conventional liver function test item, is specially adapted to the judgement of chronic hepatitis patients hepar damnification degree, observation of curative effect and state of illness monitoring.In addition it or the candidate new molecule of malaria quick diagnosis.But above-mentioned enzyme can only catalysis L-glutamic acid, can not catalysis other amino acid, purposes has been subject to certain restriction.
Summary of the invention
The 1st technical problem to be solved by this invention is to provide a kind of mutant enzyme of glutamate dehydrogenase that can the catalysis multiple amino acids.
The 2nd technical problem to be solved by this invention is the construction process of said mutation body enzyme.
The present invention obtains gdh gene from Salmonella typhimurium (Salmonella typhimurium), obtained the gene fragment of sudden change by mutant primer, the aminoacid sequence of its coding as shown in sequence table, the mutator gene fragment is connected with the pET28b plasmid, successfully builds recombinant expression plasmid pET28b-KA/LG; This recombinant plasmid transformed competent escherichia coli cell, the genetic engineering bacterium Rosetta (DE3) that structure is expressed for mutant enzyme/pET28b-KA/LG; Obtained to express preferably under 37 ℃ of normal temperature and 0.5mM IPTG condition.
The present invention compared with prior art, the engineering bacteria that generates can not only catalysis L-glutamic acid, and can also catalysis methionine(Met) and nor-leucine.
Description of drawings
Fig. 1 is the pcr amplification figure of gdh gene.
M:Marker III; The pcr amplification product of 1:gdh gene
Fig. 2 is A166G fragment PCR amplification figure
M:Marker III; 1:A166G downstream fragment; 2:A166G upstream fragment
Fig. 3 is that A166G merges pcr amplification figure
M:Marker III; 1:A166G merges the PCR product
Fig. 4 is KA/LG fragment PCR amplification figure
M:Marker III; 1:KA/LG downstream fragment; 2:KA/LG upstream fragment
Fig. 5 is that KA/LG merges pcr amplification figure
M:Marker III; 1:KA/LG merges the PCR product
Embodiment
The present invention is described in detail below in conjunction with embodiment.
Embodiment 1:
1, gdh gene gdh obtains
According to the known gdh gene design primer of Salmonella typhimurium atcc 14028 (Salmonella typhimurium), take the S.typhimurium genomic dna as template, pcr amplification, result only obtain 1 specific fragment (Fig. 1).Gdh amplimer and PCR condition are respectively:
Sense:5′-GAACCACGTCATATGGATCAGACATGTTC-3′;
Anti-sense:5′-ATCCCTCGAGAAAGCTATCTGGCCTGAC-3′;
95 ℃ of denaturation 3min; 94 ℃ of 30s, 60 ℃ of 30s, 72 ℃ of 1min 30s circulate 35 times; 72 ℃ are fully extended 10min.
2, recombinant vectors pET28b-gdh builds
The product of amplification and carrier pET28b after NdeI, Xho I double digestion, connect Transformed E .coliDH5 α respectively.Screening positive clone obtains expression plasmid pET28b-gdh.After double digestion is identified, send that the Nanjing spun gold is auspicious to check order, sequence alignment is found in full accord on sequenced genes and Genbank (GeneBank accession NO.NP_460265).
3, the structure of mutants which had
The design mutant primer, carry out pcr amplification take recombinant plasmid pET28b-gdh DNA as template, this fragment is connected with the pET28b carrier, construction recombination plasmid pET28b-A166G, transform intestinal bacteria E.coli DH5 α competent cell, through blue hickie screening, select the white clone and extract plasmid, send spun gold auspicious order-checking in Nanjing to identify.166 mutant primers and PCR condition are respectively:
166 anti-sense:5 '-GATATCCCCCCCAGGCACGTCG-3 ';
166 sense:5 '-GATACCGACGTGCCTGGGGGGGATA-3 ';
Upstream fragment (fragment that contains the gdh initiator codon): 94 ℃ of denaturation 3min; 94 ℃ of 30s, 60 ℃ of 30s, 72 ℃ of 30s circulate 35 times; 72 ℃ are fully extended 10min,
Downstream fragment (fragment that contains the gdh terminator codon): 94 ℃ of denaturation 3min; 94 ℃ of 30s, 60 ℃ of 30s, 72 ℃ of 1min circulate 35 times; 72 ℃ are fully extended 10min.Pcr amplification the results are shown in Figure 2.
The PCR product merges PCR again after gel reclaims, merge the PCR condition to be: 94 ℃ of denaturation 3min; 94 ℃ of 30s, 64 ℃ of 40s, 72 ℃ of 1min 30s circulate 35 times; 72 ℃ are fully extended 10min.The results are shown in Figure 3.
The product of amplification and carrier pET28b after NdeI, Xho I double digestion, connect Transformed E .coliDH5 α respectively.Screening positive clone obtains expression plasmid pET28b-A166G, carries out pcr amplification take recombinant plasmid pET28b-A166G as template, and this fragment is connected with the pET28b carrier, builds pET28b-KA/LG,
92 mutant primers are:
92 anti-sense:5 '-GCATACCGCC
AAGATAGGGGCCGATAG-3 ';
92 sense:5 '-TCGGCCCCTAT
CTTGGCGGTATGCG-3 '.
The PCR condition is upstream fragment (fragment that contains the gdh initiator codon): 94 ℃ of denaturation 3min; 94 ℃ of 30s, 60 ℃ of 30s, 72 ℃ of 35s circulate 35 times; 72 ℃ are fully extended 10min, downstream fragment (fragment that contains the gdh terminator codon): 94 ℃ of denaturation 3min; 94 ℃ of 30s, 60 ℃ of 30s, 72 ℃ of 1min circulate 35 times; 72 ℃ are fully extended 10min.The fragment PCR detected result is seen Fig. 4.
The PCR product merges PCR again after gel reclaims, merge the PCR condition to be: 94 ℃ of denaturation 3min; 94 ℃ of 30s, 64 ℃ of 40s, 72 ℃ of 1min 30s circulate 35 times; 72 ℃ are fully extended 10min.Result as shown in Figure 5.
Sequence alignment is found to have suddenlyd change successfully, and expression plasmid pET28b-KA/LG is converted into E.coliRosetta (DE3) competent cell, builds recombinant bacterial strain Rosetta (DE3)/pET28b-KA/LG.
4, the expression of two mutant strains and purifying
The picking recombinant bacterium in the test tube that contains 5ml LB liquid nutrient medium, 37 ℃, 225rpm, the enlarged culturing of spending the night; Culture was inoculated in the tap web bottle that contains 50ml LB liquid nutrient medium with 1: 100, and 37 ℃, 225rpm, shaking culture is to OD
600Be 0.6-0.8; Add 0.5mM isopropylthiogalactoside (isopropyl-β-D-thiogalactopyranoside, IPTG), 37 ℃ of abduction delivering 10h; 4 ℃, 5,000rpm, centrifugal 5min collects thalline, ultrasonic disruption.Use Co
2+The ion affinity column (
Purification Kit) purifying.Protein after purifying identifies through 10%SDS-PAGE, at molecular weight 47kDa place, the very high band of one specificity arranged, and illustrates that the purity of protein after purifying is higher.SDS-PAGE shows that the molecular size range of this protein is about 47kDa, and is consistent with the molecular size range that calculates by aminoacid sequence.
5, the enzyme kinetics parameter detecting of two mutant enzymes (KA/LG) and with the comparison of the parameter of wild-type StGDH
Be 50mM, NADP at Tris-HCl (pH8.0) final concentration
+Final concentration is in the fixing reaction system of 250 μ M, changes the final concentration of L-glutamic acid, with Cary 300 Bio UV-Visible spectrophotometers, detects A under 25 ℃
340Variation, parallel 3~4 secondary responses of doing of identical aminoglutaric acid concentration are averaged and are made curve, reciprocal equation formulas two according to Lineweaver-Burk are calculated the right K of each enzyme
mAnd k
catValue.Use the same method and calculate each enzyme to the K of L-Met and L-Nle
mAnd k
catValue.Result shows that this enzyme not only can be take L-glutamic acid as substrate, can also be take methionine(Met) or nor-leucine as substrate.Their K
mValue is respectively 438.76mM, 68.48mM, and 26.81mM, concrete numerical value sees Table 1.
Transformation by several amino-acid residues makes the glutamate dehydrogenase conversion for a kind of amino acid dehydrogenase of novelty, can be take METHIONINE or L-nor-leucine as substrate.This has just illustrated that also these amino acid are important amino acids that glutamate dehydrogenase and substrate Pidolidone are identified mutually.
Not only make us obtain a kind of enzyme of novelty by such transformation, and enlarged its substrate specificity, can utilize simultaneously several different substrates, this has not only increased the diversity of enzyme, and very large value is also arranged on industrial applicability.Transformation by protein engineering changes the substrate specificity of amino acid dehydrogenase, for the production of or detect natural or alpha-non-natural amino acid.
SEQUENCE LISTING
<110〉Anhui Normal University
<120〉a kind of mutant enzyme of glutamate dehydrogenase and construction process thereof
<130>1
<160>1
<170>PatentIn version 3.3
<210>1
<211>448
<212>PRT
<213〉Salmonella typhimurium (Salmonella typhimurium)
<400>1
His Met Asp Gln Thr Cys Ser Leu Glu Ser Phe Leu Asn His Val Gln
1 5 10 15
Lys Arg Asp Pro His Gln Thr Glu Phe Ala Gln Ala Val Arg Glu Val
20 25 30
Met Thr Thr Leu Trp Pro Phe Leu Glu Gln Asn Pro Arg Tyr Arg His
35 40 45
Met Ser Leu Leu Glu Arg Leu Val Glu Pro Glu Arg Val Ile Gln Phe
50 55 60
Arg Val Val Trp Leu Asp Asp Lys Asn Gln Val Gln Val Asn Arg Ala
65 70 75 80
Trp Arg Val Gln Phe Asn Ser Ala Ile Gly Pro Tyr Leu Gly Gly Met
85 90 95
Arg Phe His Pro Ser Val Asn Leu Ser Ile Leu Lys Phe Leu Gly Phe
100 105 110
Glu Gln Thr Phe Lys Asn Ala Leu Thr Thr Leu Pro Met Gly Gly Gly
115 120 125
Lys Gly Gly Ser Asp Phe Asp Pro Lys Gly Lys Ser Glu Gly Glu Val
130 135 140
Met Arg Phe Cys Gln Ala Leu Met Thr Glu Leu Tyr Arg His Leu Gly
145 150 155 160
Pro Asp Thr Asp Val Pro Gly Gly Asp Ile Gly Val Gly Gly Arg Glu
165 170 175
Val Gly Phe Met Ala Gly Met Met Arg Lys Leu Ser Asn Asn Ser Ser
180 185 190
Cys Val Phe Thr Gly Lys Gly Leu Ser Phe Gly Gly Ser Leu Ile Arg
195 200 205
Pro Glu Ala Thr Gly Tyr Gly Leu Val Tyr Phe Thr Glu Ala Met Leu
210 215 220
Lys Arg His Gly Leu Gly Phe Glu Gly Met Arg Val Ala Val Ser Gly
225 230 235 240
Ser Gly Asn Val Ala Gln Tyr Ala Ile Glu Lys Ala Met Ala Phe Gly
245 250 255
Ala Arg Val Val Thr Ala Ser Asp Ser Ser Gly Thr Val Val Asp Glu
260 265 270
Ser Gly Phe Thr Pro Glu Lys Leu Ala Arg Leu Cys Glu Ile Lys Ala
275 280 285
Ser Arg Asp Gly Arg Val Ala Asp Tyr Ala Arg Glu Phe Gly Leu Thr
290 295 300
Tyr Leu Glu Gly Gln Gln Pro Trp Ser Val Pro Val Asp Ile Ala Leu
305 310 315 320
Pro Cys Ala Thr Gln Asn Glu Leu Asp Val Asp Ala Ala Arg Val Leu
325 330 335
Ile Ala Asn Gly Val Lys Ala Val Ala Glu Gly Ala Asn Met Pro Thr
340 345 350
Thr Ile Glu Ala Thr Asp Leu Phe Leu Glu Ala Gly Val Leu Phe Ala
355 360 365
Pro Gly Lys Ala Ala Asn Ala Gly Gly Val Ala Thr Ser Gly Leu Glu
370 375 380
Met Ala Gln Asn Ala Ala Arg Leu Ser Trp Lys Ala Glu Lys Val Asp
385 390 395 400
Ala Arg Leu His His Ile Met Leu Asp Ile His His Ala Cys Val Glu
405 410 415
Tyr Gly Gly Asp Asn Lys His Thr Asn Tyr Val Gln Gly Ala Asn Ile
420 425 430
Ala Gly Phe Val Lys Val Ala Asp Ala Met Leu Ala Gln Gly Val Ile
435 440 445
Claims (2)
1. the mutant enzyme of a glutamate dehydrogenase, it is characterized in that: it is comprised of the aminoacid sequence shown in SEQ ID NO:1.
2. the gene of the mutant enzyme of the described glutamate dehydrogenase of claim 1 of encoding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110059834 CN102199578B (en) | 2011-03-14 | 2011-03-14 | Mutant enzyme of glutamate dehydrogenase and construction method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110059834 CN102199578B (en) | 2011-03-14 | 2011-03-14 | Mutant enzyme of glutamate dehydrogenase and construction method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102199578A CN102199578A (en) | 2011-09-28 |
CN102199578B true CN102199578B (en) | 2013-06-19 |
Family
ID=44660567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110059834 Expired - Fee Related CN102199578B (en) | 2011-03-14 | 2011-03-14 | Mutant enzyme of glutamate dehydrogenase and construction method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102199578B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3677673A4 (en) * | 2018-03-09 | 2021-08-04 | Zhejiang University | Glutamate dehydrogenase mutant and use thereof in preparing l-glufosinate |
EP3783101A4 (en) * | 2018-04-03 | 2022-01-19 | Abiochem Biotechnology Co., Ltd. | L-glutamate dehydrogenase mutant and application thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103074309B (en) * | 2012-09-11 | 2014-04-16 | 河北师范大学 | L-alanine dehydrogenase mutant zymoprotein and preparation method thereof |
CN103725655B (en) * | 2013-12-27 | 2016-10-05 | 东北农业大学 | A kind of Novel herbicide resistance protein and encoding gene thereof and application |
CN106085977B (en) * | 2016-06-08 | 2019-11-01 | 西北工业大学 | The recombination and its acquisition methods of glutamte dehydrogenase and application |
CN110184246B (en) * | 2019-05-15 | 2020-10-13 | 浙江大学 | Glutamate dehydrogenase mutant and application thereof |
CN110592036A (en) * | 2019-08-30 | 2019-12-20 | 浙江工业大学 | Glufosinate-ammonium dehydrogenase mutant and application thereof in producing L-glufosinate-ammonium by oxidation-reduction multi-enzyme coupling |
CN112342224B (en) * | 2020-11-24 | 2022-09-20 | 中国科学院海洋研究所 | Porphyra haitanensis glutamate dehydrogenase gene and application thereof |
CN112280760B (en) * | 2020-11-26 | 2022-04-15 | 宿迁市江南大学产业技术研究院 | Glutamic dehydrogenase mutant and application thereof |
CN116463304B (en) * | 2023-06-14 | 2023-09-05 | 黑龙江伊品生物科技有限公司 | Threonine dehydrogenase gene mutant and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006138689A2 (en) * | 2005-06-17 | 2006-12-28 | Microbia, Inc. | Improved amino acid and metabolite biosynthesis |
CN101705238A (en) * | 2009-09-24 | 2010-05-12 | 上海交通大学 | Bacillus natto glutamic acid dehydrogenase coding genes, protein and bacterial strain |
-
2011
- 2011-03-14 CN CN 201110059834 patent/CN102199578B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006138689A2 (en) * | 2005-06-17 | 2006-12-28 | Microbia, Inc. | Improved amino acid and metabolite biosynthesis |
CN101705238A (en) * | 2009-09-24 | 2010-05-12 | 上海交通大学 | Bacillus natto glutamic acid dehydrogenase coding genes, protein and bacterial strain |
Non-Patent Citations (1)
Title |
---|
陈丽丽等.纳豆芽孢杆菌谷氨酸脱氢酶基因的克隆、表达及酶活性测定.《上海交通大学学报(农业科学版)》.2010,第28卷(第1期),82-86. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3677673A4 (en) * | 2018-03-09 | 2021-08-04 | Zhejiang University | Glutamate dehydrogenase mutant and use thereof in preparing l-glufosinate |
EP3783101A4 (en) * | 2018-04-03 | 2022-01-19 | Abiochem Biotechnology Co., Ltd. | L-glutamate dehydrogenase mutant and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102199578A (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102199578B (en) | Mutant enzyme of glutamate dehydrogenase and construction method thereof | |
CN103710321B (en) | Nicotinamide mononucleotide adenylyltransferase (Nmnat) mutant as well as coding gene and application thereof | |
CN103074309B (en) | L-alanine dehydrogenase mutant zymoprotein and preparation method thereof | |
CN108060142A (en) | The enzyme of biogenic amine in a kind of degradation soy sauce | |
CN108795916A (en) | Lysine decarboxylase mutant, coding gene thereof, expression and application thereof | |
CN104774813B (en) | Leucine dehydrogenase and preparation method and application thereof | |
CN103103167A (en) | Mutant zymoprotein of D-amino acid oxidase and preparation method of mutant zymoprotein | |
Zhang et al. | Characterization of a novel alkaline Arxula adeninivorans urate oxidase expressed in Escherichia coli and its application in reducing uric acid content of food | |
CN105420206B (en) | A kind of glutamine transaminage that thermal stability improves | |
CN108118037A (en) | The glucose oxidase mutant that a kind of heat resistance improves | |
CN114395541A (en) | Glucose oxidase mutant GOx1-MUT with improved thermal stability and specific activity, and coding gene and application thereof | |
WO2024045796A1 (en) | Cyclodextrin glucosyltransferase with improved solvent tolerance and preparation thereof | |
CN113151235A (en) | Recombinant L-arabinose isomerase LPAI and construction method and application thereof | |
CN114990043B (en) | Engineering bacterium for metabolizing lysine as well as construction method and application thereof | |
CN110592055A (en) | Creatine hydrolase mutant with improved thermal stability | |
CN113061593B (en) | L-malate dehydrogenase mutant and application thereof | |
Sauvageot et al. | Aerobic glycerol dissimilation via the Enterococcus faecalis DhaK pathway depends on NADH oxidase and a phosphotransfer reaction from PEP to DhaK via EIIADha | |
Wang et al. | Cloning, expression and characterization of d-aminoacylase from Achromobacter xylosoxidans subsp. denitrificans ATCC 15173 | |
CN111004794B (en) | Subtilisin E mutant with improved thermal stability and application thereof | |
CN112921010A (en) | Multi-copper oxidase recombinase suitable for fermented food | |
CN115851681A (en) | Creatine amidino hydrolase mutant with improved activity | |
CN115927228B (en) | Mutant and construction method and application thereof | |
CN114621944B (en) | Arginine deiminase mutant with improved enzyme activity | |
CN111593038B (en) | Glutaminase mutant with improved stability | |
CN106520713A (en) | Genetic engineering strain being capable of producing acetyl coenzyme A oxidase and having good heat stability as well as construction method and applications of genetic engineering strain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130619 |